Quantedge Capital’s BlueLinx BXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-8,100
Closed -$854K 141
2024
Q3
$854K Buy
+8,100
New +$828K 0.25% 92
2024
Q2
Sell
-18,600
Closed -$2.42M 178
2024
Q1
$2.42M Sell
18,600
-1,200
-6% -$141K 1.02% 31
2023
Q4
$2.24M Sell
19,800
-300
-1% -$26K 1.1% 26
2023
Q3
$1.65M Sell
20,100
-1,400
-7% -$123K 0.9% 37
2023
Q2
$2.02M Sell
21,500
-5,100
-19% -$408K 0.9% 35
2023
Q1
$1.81M Buy
26,600
+2,100
+9% +$170K 0.71% 41
2022
Q4
$1.74M Sell
24,500
-25,900
-51% -$1.77M 0.58% 54
2022
Q3
$3.13M Sell
50,400
-18,200
-27% -$1.31M 0.97% 35
2022
Q2
$4.58M Buy
68,600
+2,800
+4% +$210K 0.92% 32
2022
Q1
$4.73M Buy
65,800
+38,100
+138% +$3.12M 1.4% 18
2021
Q4
$2.65M Buy
+27,700
New +$1.88M 1.12% 23

Other funds holding BXC

Quantedge Capital's BXC Position: Q4 2024 in Review

Quantedge Capital sold out of BlueLinx (BXC) in Q4 2024, closing a stake of 8,100 shares — an estimated $854K sold.

Quantedge Capital first reported a position in BXC in Q4 2021 and held it in 11 quarters. The position peaked at $4.73M in Q1 2022. 175 funds tracked by Wall St. Rank hold BXC as of Q4 2024.

  • Quantedge Capital reported no remaining BlueLinx position as of Q4 2024 after selling out during the quarter.
  • Quantedge Capital sold 8,100 BlueLinx shares in Q4 2024, an estimated $854K.
  • Quantedge Capital first reported a position in BlueLinx in Q4 2021 and held it in 11 quarters.
  • Quantedge Capital's BlueLinx position peaked at $4.73M in Q1 2022.
  • 175 funds tracked by Wall St. Rank held BlueLinx as of Q4 2024.

Based on Quantedge Capital's 13F filing for Q4 2024, filed 14 Feb 2025.